BRIEF published on 02/29/2024 at 20:11, 1 year 9 months ago BRAIN Biotech AG Announces Issuance of EUR 5 Million Convertible Bond Convertible Bonds Shareholder Rights Financial Strategy BRAIN Biotech AG Corporate Financing
PRESS RELEASE published on 02/29/2024 at 20:06, 1 year 9 months ago EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights BRAIN Biotech AG issues EUR 5 million convertible bond without subscription rights, to be issued on 5 March 2024. Bonds have 6.52% interest rate and due for repayment in 2026 Convertible Bond BRAIN Biotech AG Subscription Rights Interest Rate Repayment
PRESS RELEASE published on 02/28/2024 at 07:30, 1 year 9 months ago 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 BRAIN Biotech AG reports optimistic outlook for fiscal year 2023/24 with strong start in BioScience business. Quarterly report includes details on revenue and segment performance Revenue Growth Financial Performance BRAIN Biotech AG Fiscal Year 2023/24 BioScience Business
BRIEF published on 02/28/2024 at 07:30, 1 year 9 months ago BRAIN Biotech AG: Review of the first quarter of the 2023/24 financial year Financial Report Organic Growth BRAIN Biotech AG BioScience BioProducts
PRESS RELEASE published on 09/28/2023 at 10:30, 2 years 2 months ago BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition
PRESS RELEASE published on 09/14/2023 at 10:30, 2 years 2 months ago BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®
PRESS RELEASE published on 09/12/2023 at 15:45, 2 years 2 months ago BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
PRESS RELEASE published on 08/30/2023 at 07:30, 2 years 3 months ago BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions
PRESS RELEASE published on 06/28/2023 at 13:00, 2 years 5 months ago BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition
PRESS RELEASE published on 06/19/2023 at 12:30, 2 years 5 months ago Anniversary of BRAIN Biotech AG: 30 years for a bio-based future
Published on 12/05/2025 at 02:35, 8 hours 22 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 9 hours 57 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 52 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 57 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 10:30, 27 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 41 minutes ago Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 16 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 27 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 51 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 2 hours 12 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 57 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 17 hours 12 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 17 hours 12 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
